← Back to Search

Intervention for Hypertension (RESET-BP Trial)

N/A

Waitlist Available

Led By Bethany Barone Gibbs, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

RESET-BP Trial Summary

This trial is testing a new sedentary behavior intervention to see if it can lower blood pressure in adults. The primary outcome is resting systolic blood pressure (SBP) at 3 months.

Eligible Conditions

Hypertension
High Blood Pressure

RESET-BP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Resting Systolic Blood Pressure

Secondary outcome measures

24-hour Ambulatory Blood Pressure

Aldosterone

Diastolic Blood Pressure

+2 more

Other outcome measures

Adverse Events

Glucose

Insulin

+1 more

RESET-BP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The intervention will use behavioral strategies (self-monitoring, goal setting, problem solving, social support, stimulus control), environment modification (sit-stand attachment), and proximal (activity prompter) and distal (text messages) external prompts to target a 2-4 hour/day reduction in sedentary behavior.

Group II: ControlActive Control1 Intervention

Participants randomized to the control condition will receive no intervention during the study. After the 3-month assessment, control participants will be provided with a wrist-worn activity monitor and will be offered the 3-month delayed intervention if desired to aid in retention and recruitment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intervention

2011

Completed Phase 4

~73780

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,828 Previous Clinical Trials

47,300,483 Total Patients Enrolled

468 Trials studying Hypertension

2,150,895 Patients Enrolled for Hypertension

University of PittsburghLead Sponsor

1,718 Previous Clinical Trials

16,343,312 Total Patients Enrolled

31 Trials studying Hypertension

49,006 Patients Enrolled for Hypertension

Bethany Barone Gibbs, PhDPrincipal Investigator - University of Pittsburgh

University of Pittsburgh

3 Previous Clinical Trials

658 Total Patients Enrolled

1 Trials studying Hypertension

120 Patients Enrolled for Hypertension

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts still underway for this research project?

"According to clinicaltrials.gov, this medical trial is no longer active; the first post was on March 1st 2018 and it had been updated as recently as September 8th 2022. Nevertheless, there are currently 754 other trials looking for participants at this time."

Answered by AI

Is there any opportunity to join the research program?

"Prospective participants for this trial should have hypertension and fall into the age bracket of 21 to 65 years old. The investigators are aiming to recruit a total of 300 patients."

Answered by AI